Ceigall India Appoints New Directors and Re-appoints Two Independent Directors Post AGM
Ceigall India Limited's AGM on September 29, 2026, saw the re-appointment of Mr. Vishal Anand and Mrs. Gurpreet Kaur as Non-Executive Independent Directors for five-year terms. Additionally, Mr. Ankit Kumar Agarwal was appointed as a Non-Executive Independent Director, and Mr. Ayyalusamy Saravanan and Dr. Pawan Kumar were appointed as Whole Time Directors, each for five and two-year terms respectively.
Changes in key management and board composition can influence strategic decisions and company direction, thus having a medium-term impact.
The appointment and re-appointment of directors indicate continued governance and strategic direction for the company.
Ceigall India Limited announced the outcome of its 24th Annual General Meeting (AGM) held on September 29, 2026. The members approved key changes in the management structure.
Mr. Vishal Anand has been re-appointed as a Non-Executive Independent Director for a second term of five consecutive years, effective October 26, 2026, until October 25, 2031. Similarly, Mrs. Gurpreet Kaur has also been re-appointed as a Non-Executive Independent Director for her second term of five years, commencing July 1, 2026, and concluding on June 30, 2031.
Furthermore, the company has appointed Mr. Ankit Kumar Agarwal as a Director and Non-Executive Independent Director for a first term of five years, starting July 1, 2026, and ending June 30, 2031. Mr. Ayyalusamy Saravanan has been appointed as a Director and Whole Time Director for a two-year term, from July 1, 2026, to June 30, 2028. Dr. Pawan Kumar has also been appointed as a Director and Whole Time Director for a two-year term, from July 1, 2026, to June 30, 2028. All appointed directors are not related to any existing directors or key managerial personnel and are not debarred from holding directorships by any regulatory authority.
What to do with a filing like this
Ceigall India Limited filed this with the NSE as a statutory disclosure, categorised under board changes. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Ceigall India Limited. Read the original for the full detail.